Loss-of-function mutations in CYP24A1 were first identified in infants with idiopathic infantile hypercalcemia and have since been recognized to cause a spectrum of symptoms across all age groups.5,6,7. This evidence concerns the gene CYP24A1 and hypercalcemia disease.